Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery

NCT01346969 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Reduction in Hypertrophic Skin Scarring

Interventions

DRUG: EXC 001
DRUG: EXC 001
DRUG: EXC 001
DRUG: EXC 001

Sponsor

Pfizer